About Astellas

News Release

Get Adobe ReaderTo view and print the files,
you must have Adobe Reader.

2007

December 27,2007 Astellas Won the Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon® Capsule (PDF 34KB)
December 18,2007 Announcement of the Launch of the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60μg in Japan (PDF 115KB)
November 30,2007 Sanofi-aventis and Astellas to restructure their joint venture activities of Fujisawa sanofi-aventis K.K. in Japan (PDF 25KB)
November 27,2007 Astellas to Acquire Agensys, Inc. (PDF 382KB)
November 22,2007 Astellas Announces Acquisition of Treasury Shares (PDF 24KB)
November 14,2007 SNDA FOR A FAST-ACTING POSTPRANDIAL HYPOGLICEMIC AGENT FASTIC® TABLET / STARSIS® TABLET FOR COMBINATION THERAPY WITH BIGUANIDE WAS APPROVED (PDF 35KB)
November 8,2007 Astellas and Boehringer Ingelheim Reach Settlement Agreement with Ranbaxy on Flomax Patent Case (PDF 9KB)
November 2,2007 Astellas Establishes a Liaison Office in India (PDF 23KB)
October 23,2007 Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections (PDF 39KB)
October 23,2007 ADENOSCAN® PATENT LAWSUITS SETTLED (PDF 39KB)
October 22,2007 Announcement of the Acquisition of Marketing Approval for the Pulmonary Arterial Hypertension Agent Careload® LA Tablets 60μg in Japan (PDF 106KB)
October 4,2007 Announcement of the Launch of Geninax® Tablet, an Oral New-Type Quinolone Antibacterial Agent, in Japan (PDF 15KB)
October 3,2007 Astellas Completed the Early Retirement Program to Japanese Employees (PDF 24KB)
September 19,2007 Astellas Submitted a Response to the FDA Action Letter for FK506 Modified Release Formulation for Kidney Transplantation (PDF 26KB)
September 12,2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485 (PDF 25KB)
September 11,2007 Notice of Completion of Acquisition of the Company's Own Shares (PDF 23KB)
September 10,2007 Court Dismisses Appeal Filed by Taiyo Yakuhin Co., Ltd. of Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon® Capsule (PDF 27KB)
September 6,2007 Notice of the Result of Acquisition of the Company's Own Shares Through ToSTNeT-2 (PDF 23KB)
September 5,2007 Notice of Acquisition of the Company's Own Shares Through ToSTNeT-2 (PDF 25KB)
September 3,2007 Astellas Announces the Extension of US Regulatory Review for the sNDA of MYCAMINE® (PDF 24KB)
August 28,2007 Astellas Announces Acquisition of The Companyfs Own Shares (Share buyback pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act) (PDF 23KB)
August 10,2007 Contents of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan) (PDF 23KB)
August 9,2007 Astellas Filed a Lawsuit against Taiyo Yakuhin Co., Ltd. Claiming Damages on the Oral Cephalosporin Antibiotic Cefzon® (PDF 29KB)
August 1,2007 Reorganization of Astellas European Business Function (PDF 32KB)
July 26,2007 Allotment of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan) (PDF 58KB)
July 3,2007 Kyoto University and Astellas Co-research at the Innovation Center for Immunoregulation Technologies and Drugs of Next Generation (PDF 13KB)
June 26,2007 Astellas Set Up The Nomination Committee and The Compensation Committee (PDF 24KB)
June 18,2007 Astellas Announces the Launch of Advagraf® in the UK and Germany (PDF 24KB)
June 11,2007 Announcement of the Launch of the Selective COX-2 Inhibitor Celecox® Tablets in Japan (PDF 15KB)
May 15,2007 Partial Amendments to the Articles of Incorporation (PDF 81KB)
May 15,2007 Issuance of Stock Acquisition Rights for Stock Option Scheme as Stock-Linked Compensation Plan (PDF 28KB)
May 07,2007 Adverse Event of FG-2216 for the Treatment of Anemia (PDF 26KB)
May 01,2007 Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe (PDF 25KB)
April 27,2007 Astellas Receives an European Commission Approval for Advagraf® (PDF 24KB)
April 26,2007 Astellas Will Set Up The Nomination Committee and The Compensation Committee (PDF 24KB)
April 26,2007 Astellas Nominates a Director and Corporate Auditors (PDF 24KB)
April 2,2007 Astellas Tokai Completed Merger with Two Group Companies (PDF 24KB)
March 30,2007 ASTELLAS LICENSES REGENERON'S VELOCIMMUNE® TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES (PDF 22KB)
March 26,2007 Astellas Announces Cancellation of Treasury Stock (PDF 24KB)
March 26,2007 Astellas Assigns All Outstanding Shares of Its Production Subsidiary to Choseido (PDF 24KB)
March 20,2007 Astellas Receives an FDA Action Letter for Prograf sNDA (PDF 27KB)
March 2,2007 FDA APPROVES ASTELLAS' VAPRISOL® FOR THE TREATMENT OF HYPERVOLEMIC HYPONATREMIA (PDF 59KB)
February 28,2007 Astellas Constructs New Buildings at its Miyukigaoka Research Center in Tsukuba (PDF26KB)
February 26,2007 Astellas Receives a Positive CHMP Opinion for EU Marketing Authorisation for FK506 Modified Release as a Once-Daily Immunosuppressant in Organ Transplantation (PDF18KB)
February 23,2007 ASTELLAS AND BOEHRINGER WON THE LAWSUIT AGAINST FLOMAX® GENERIC FOR PATENT INFRINGEMENT IN THE USA (PDF23KB)
February 13,2007 Contents of Stock Acquisition Rights (Stock Option Scheme as Stock-Linked Compensation Plan) (PDF23KB)
February 01,2007 Astellas Will Offer an Early Retirement Program to Japanese Employees (PDF24KB)
January 29,2007 Notice of Intention to Exercise Call Option on 1.25% Convertible Bonds due 2014 (PDF23KB)
January 26,2007 Astellas and Pfizer Reached Settlement on Declaratory Judgment Action relating to Lipitor Agreement (PDF12KB)
January 26,2007 Allotment of Stock Acquisition Rights(Stock Option Scheme as Stock-Linked Compensation Plan) (PDF57KB)
January 26,2007 Approval for Candin Antifungal Agent Funguard for Prophylaxis of Aspergillus and Candida infections in patients undergoing HSCT and Immunosuppressant Prograf for Lupus Nephritis in Japan (PDF17KB)
January 26,2007 Announcement of the Acquisition of Marketing Approval for the Selective COX-2 Inhibitor Celecox Tablet in Japan (PDF12KB)
January 24,2007 Kirin and Astellas Enter Into a Licensing Agreement on an Immunosuppressive Fully Human Monoclonal Antibody (PDF21KB)
January 23,2007 Astellas Receives an Action Letter from FDA for NDA of FK506 MR in the U.S. (PDF 24KB)
January 11,2007 Astellas Terminates Agreement on Acute Heart Failure Agent Carperitide(PDF 23KB)